Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
guidance
Pharma
EuroAPI suspends 2024 guidance amid Italian production deficits
After reporting ballooning losses last month, EuroAPI revealed Friday that manufacturing lapses have temporarily derailed its guidance for the year.
Fraiser Kansteiner
Mar 15, 2024 11:12am
Pfizer's 2024 revenue forecast triggers drop in share price
Dec 13, 2023 11:11am
Lilly, AbbVie set for success late in decade, but BMS may suffer
Apr 7, 2022 3:15pm
Sanofi wants ACIP to fine tune its influenza vaccine guidelines
Feb 24, 2022 9:05am
Amgen sees mid-single-digit CAGR growth to end of decade
Feb 8, 2022 2:30pm
Lilly bumps up revenue projections for 2021, 2022
Dec 15, 2021 11:21am
